The Pocket Guide for Psoriasis and Psoriatic Arthritis
The significant progress made in psoriatic disease research since the launch of the National Psoriasis Foundation in 1967 has expanded our knowledge base and led to the development of life-changing treatment options. These options include:
Topicals
Phototherapy
Systemics
Biologics
Oral Treatments
Even with all the information available today, providers may still have questions. For example:
Are patients with chronic plaque psoriasis candidates for UVB phototherapy?
Are all systemic treatments also biologics?
What are the side effects of adalimumab?
Answers to these questions and more are easily accessible in the The Psoriasis and Psoriatic Arthritis Pocket Guide – Treatment Algorithms and Management Options.
The most recent edition has been updated to include newly published guideline recommendations for both psoriasis and psoriatic arthritis management, and includes updates to new and existing treatment options.
After studying this handbook, physicians should be able to:
Define the severity of psoriasis and develop an appropriate therapy plan.
Explain the profound emotional, social and physical impact psoriatic disease has on the patient.
Understand the important comorbidities associated with psoriasis.
Differentiate psoriasis from other diseases after evaluating patients who present with similar types of skin lesions.
Diagnose patients who have moderate disease (3% to 10% body involvement) and severe disease (>10% body involvement).
Updated August 2022 by the National Psoriasis Foundation.
Sponsor Acknowledgements
NPF would like to thank the following sponsors of The Psoriasis and Psoriatic Arthritis Pocket Guide:
Bristol-Myers Squibb Janssen UCB, Inc.
We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.